Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

2
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
2
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

106
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
106
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.5K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.5K
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

3
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
3
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

4
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
4
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

128
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
128

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harmonized metagenomic signatures of the gut microbiome reveal robust species, functions, and strain links to inflammatory bowel disease.

Gastroenterology·2026
Same author

Circulating imidazole propionate and coronary heart disease risk: interplay between histidine intake, fiber, and gut microbiome.

BMC medicine·2026
Same author

Item recognition is associated with gut microbiota composition in healthy humans.

Learning & memory (Cold Spring Harbor, N.Y.)·2026
Same author

Embedding Lived Expertise into Military and Veteran Medical Research.

Military medicine·2026
Same author

Shotgun Metagenomic Profiling of the Gut Virome in Prodromal and Confirmed Parkinson's Disease.

Annals of neurology·2026
Same author

Long-lasting gut microbiome and fecal metabolome alterations after colorectal adenoma removal and their relationship to colorectal cancer.

Cell host & microbe·2026

Related Experiment Video

Updated: Apr 18, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.7K

Complex host genetics influence the microbiome in inflammatory bowel disease.

Dan Knights1, Mark S Silverberg2, Rinse K Weersma3

  • 1Department of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota 55455 USA ; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142 USA ; Center for Computational and Integrative Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114 USA ; Biotechnology Institute, University of Minnesota, St. Paul, Minnesota 55108 USA.

Genome Medicine
|January 15, 2015
PubMed
Summary

Host genetics and gut microbes interact to influence inflammatory bowel disease (IBD) risk. This study links specific genetic variations, like NOD2, to changes in gut bacteria, revealing complex genome-microbiome interactions in IBD.

More Related Videos

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.8K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

17.9K

Related Experiment Videos

Last Updated: Apr 18, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.7K
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.8K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

17.9K

Area of Science:

  • Human genetics
  • Microbiome research
  • Immunology

Background:

  • Host genetics and gut microbial communities are independently linked to chronic diseases, notably inflammatory bowel disease (IBD).
  • IBD risk is not fully explained by genetics or microbiome alone, suggesting interplay between them.
  • Previous research indicates partial heritability of the gut microbiota and microbiome-driven inflammation, even with genetic origins.

Purpose of the Study:

  • To investigate complex genome-microbiome associations in large cohorts of patients with immunity-related diseases.
  • To compare genome-microbiome associations directly in IBD patients.
  • To identify host genetic factors influencing microbial composition in IBD.

Main Methods:

  • Collected 16S rRNA gene sequences from intestinal biopsies and host genotype data (Immunochip) from three independent cohorts (n=474).
  • Correlated bacterial taxa abundance with minor allele counts at IBD risk loci, including fine-mapping NOD2 gene variants.
  • Identified conserved host polymorphism-bacterial taxa associations across cohorts and tested related genes for functional pathway enrichment.

Main Results:

  • Confirmed a significant association between NOD2 risk allele count and increased Enterobacteriaceae abundance across cohorts.
  • Identified 48 additional IBD-related SNPs with conserved associations to bacterial taxa.
  • These associations implicated genes involved in innate immune response regulation and the JAK-STAT cascade.

Conclusions:

  • Complex interactions exist between genetically influenced host pathways and microbiome structure in IBD.
  • Paired genome-microbiome data can uncover novel associations.
  • Findings suggest a complex relationship between host genetics and microbial dysbiosis in IBD patients across independent cohorts.